Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy
- 1 April 1996
- journal article
- Published by Elsevier in The Lancet
- Vol. 347 (9009), 1151-1155
- https://doi.org/10.1016/s0140-6736(96)90610-8
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors.Journal of Clinical Investigation, 1994
- Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart.Journal of Clinical Investigation, 1993
- Endothelial function in congestive heart failureAmerican Heart Journal, 1993
- Expression of intercellular adhesion molecule-1 in murine hearts with acute myocarditis caused by coxsackievirus B3.Journal of Clinical Investigation, 1993
- Nitric oxide synthase activities in human myocardiumThe Lancet, 1993
- Negative Inotropic Effects of Cytokines on the Heart Mediated by Nitric OxideScience, 1992
- Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure.Heart, 1991
- Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathyJournal of the American College of Cardiology, 1990
- The morphologic spectrum of dilated cardiomyopathy and its relation to immune-response genesThe American Journal of Cardiology, 1989
- DETECTION OF COXSACKIE-B-VIRUS-SPECIFIC RNA SEQUENCES IN MYOCARDIAL BIOPSY SAMPLES FROM PATIENTS WITH MYOCARDITIS AND DILATED CARDIOMYOPATHYThe Lancet, 1986